We have recently shown that both APOE ε4 and PRS for AD predicted aging-related cognitive decline across 25 years in individuals that remained healthy at follow-up, where the effect of PRS was seen already six years prior to diagnostic follow-up8. This evidence concerns the gene APOE and Alzheimer disease.